All companies, by profit
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net profit | Quarter |
|---|---|---|---|---|---|
| Not ranked below this line: we do not hold four quarters in a row, or a quarter's bottom line is withheld because the filing's copy of it cannot be trusted, so the figure is not the same quantity as the ones above it. | |||||
| – |
|
$122B | $95.55 +0.9% | $8.9B 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| – |
|
$642B | $266.32 +0.3% | $10.8B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 JNJ Johnson & Johnson |
| – |
|
$357B | $144.85 +0.6% | $15.3B 3 of four quarters in a row 2025: Q1, Q2, Q3 | Q3 FY25 MRK Merck & Co. |
| Not ranked below this line: these companies report in another currency, so their figures cannot be ordered against dollars. | |||||
| – | ASML outside the index ASML outside the index Share price: $1,575.15 −7.3% Q2 FY26 ASML ASML | – | $1,575.15 −7.3% | €10.6B EUR Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ASML ASML |
| – | TSM outside the index TSMC outside the index Share price: $418.01 −3.5% Q2 FY26 TSM TSMC | – | $418.01 −3.5% | NT$2,237.1B TWD Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 TSM TSMC |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.